Version 1.4, revision planned in 2012.
Last revised in April 2008
October 2009 — minor update to include new information from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding varenicline and suicidal thoughts and behaviour [MHRA, 2009a], and regarding drug interactions with smoking cessation [MHRA, 2009b]. Issued in October 2009.
April 2009 — updated to include the indicators related to smoking cessation in the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract in the Goals and outcome measures section. Issued in May 2009.
January 2009 — minor typographical correction. Issued in February 2009.
August 2008 — minor update to include updated advice from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding varenicline and suicidal thoughts and behaviour [MHRA, 2008b]. Issued in August 2008.
November 2007 to April 2008 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.